Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Human Papillomavirus Recombinant Vaccine nonavalent × Tumor-Agnostic × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Gynecologic 1

Conditions

Interventions

Specimen Handling 15 Biopsy 15 Magnetic Resonance Spectroscopy 10 pembrolizumab 9 Paclitaxel 6 trastuzumab deruxtecan 4 Taxes 4 Interviews as Topic 4 Focus Groups 4 Cyclophosphamide 4 ipatasertib 3 atezolizumab 3 X-Rays 3 Standard of Care 3 Oxaliplatin 3 Leucovorin 3 Irinotecan 3 Fulvestrant 3 Fluorouracil 3 Drug Therapy 3 Carboplatin 3 Capecitabine 3 130-nm albumin-bound paclitaxel 3 zolbetuximab 2 tislelizumab 2 talazoparib 2 sintilimab 2 palbociclib 2 olaparib 2 nilotinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06658405 2026-03-18

HPV2

Centre Oscar Lambret

Phase 2 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡